Skip to main content

Table 2 Variations in the number of neoplastic cells versus normal white cell populations in one MF patient over the course of treatment.

From: A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy

Date of sample

White blood cell count (× 103/μL)

Tumor cells*

Normal white blood cell populations

   

CD4 (+) T-cells

CD8 (+) T-cells

NK & B-cells

grans

monos

7/26/00

2.8

25%

6%

1%

13%

42%

13%

9/5/00

4.2

5%

2%

4%

3%

85%

1%

9/22/00

5

10%

2%

3%

2%

79%

4%

11/11/00

5.5

16%

2%

1%

4%

76%

1%

  1. *Tumor cells had a CD3(+)CD4(-)CD8(-) immunophenotype, allowing accurate separation from normal T-cell populations.